• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UBSEBIO:LX

395.83 USD 8.30 2.14%

As of 00:59:30 ET on 04/16/2014.

Snapshot for UBS Lux Equity Fund - Biotech USD (UBSEBIO)

Year To Date: +0.07% 3-Month: -12.33% 3-Year: +22.86% 52-Week Range: 312.09 - 503.73
1-Month: -14.70% 1-Year: +24.86% 5-Year: +24.99% Beta vs NSESWRLD: 0.90

Mutual Fund Chart for UBSEBIO

No chart data available.
  • UBSEBIO:LX 395.83
  • 1M
  • 1Y
Interactive UBSEBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBSEBIO

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: 10-18-1996 Telephone: 352-44-10-10-1 Tel
Managers: NATHALIE LOTSCHER PETRUS / CHRISTIAN SUTER
Web Site: www.ubs.com

Fundamentals for UBSEBIO

NAV (on 2014-04-16) 395.83
Assets (M) (on 2014-04-16) 953.12
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment -

Dividends for UBSEBIO

No dividends reported

Fees & Expenses for UBSEBIO

Front Load -
Back Load 2.00
Current Mgmt Fee 2.04
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.09

Top Fund Holdings for UBSEBIO

Filing Date: 02/28/2014
Name Position Value % of Total
Gilead Sciences Inc 1,415,600 117,197,524 9.296%
Biogen Idec Inc 322,900 110,005,572 8.725%
Amgen Inc 750,114 93,029,138 7.379%
Celgene Corp 447,160 71,880,970 5.701%
Regeneron Pharmaceuticals Inc 207,100 68,860,750 5.462%
BioMarin Pharmaceutical Inc 764,000 61,884,000 4.908%
Alexion Pharmaceuticals Inc 337,800 59,723,040 4.737%
Incyte Corp Ltd 784,800 50,431,248 4.000%
Vertex Pharmaceuticals Inc 610,100 49,332,686 3.913%
Medivation Inc 634,800 45,648,468 3.621%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil